H Beckmann
Overview
Explore the profile of H Beckmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
299
Citations
2735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saxena K, Lalezari S, Oldenburg J, Tseneklidou-Stoeter D, Beckmann H, Yoon M, et al.
Haemophilia
. 2016 Jun;
22(5):706-12.
PMID: 27339736
Introduction: BAY 81-8973 (Kovaltry(®) ) is a full-length, unmodified recombinant human factor VIII (FVIII) with the same amino acid sequence as sucrose-formulated recombinant FVIII and is produced using additional advanced...
2.
Kitchen S, Beckmann H, Katterle Y, Bruns S, Tseneklidou-Stoeter D, Maas Enriquez M
Haemophilia
. 2016 Apr;
22(3):e192-9.
PMID: 27030173
Introduction: BAY 81-8973 is a full-length, unmodified, recombinant human factor VIII (FVIII) with the same primary amino acid sequence as sucrose-formulated recombinant FVIII but produced with certain more advanced manufacturing...
3.
Kitchen S, Katterle Y, Beckmann H, Maas Enriquez M
J Thromb Haemost
. 2016 Mar;
14(6):1192-9.
PMID: 27002680
Unlabelled: Essentials Discrepancies can exist in factor VIII activity measured by the one-stage or chromogenic assays. LEOPOLD trial data were used to assess clinical impact of BAY 81-8973 potency assignment...
4.
Oldenburg J, Windyga J, Hampton K, Lalezari S, Tseneklidou-Stoeter D, Beckmann H, et al.
Haemophilia
. 2016 Mar;
22(3):349-53.
PMID: 26931631
Introduction: BAY 81-8973 is a recombinant factor VIII (rFVIII) with the same amino acid sequence as Bayer's sucrose-formulated rFVIII (rFVIII-FS) but manufactured with certain more advanced technologies. Aim: To describe...
5.
Kavakli K, Yang R, Rusen L, Beckmann H, Tseneklidou-Stoeter D, Maas Enriquez M
J Thromb Haemost
. 2014 Dec;
13(3):360-9.
PMID: 25546368
Background: BAY 81-8973 is a new full-length human recombinant factor VIII product manufactured with technologies to improve consistency in glycosylation and expression to optimize clinical performance. Objectives: To demonstrate superiority...
6.
Kniemeyer H, Voshege M, Soliman A, Abu Al Nasr T, Beckmann H, Edelmann M
J Cardiovasc Surg (Torino)
. 2012 Mar;
53(2):241-6.
PMID: 22456648
Spontaneous recanalization of the internal carotid artery (ICA) is rarely observed. Mainly case reports are published. Most often early recanalization occurs within days or weeks and only a few cases...
7.
Rupprecht R, Kornhuber J, Wodarz N, Gobel C, Lugauer J, Sinzger C, et al.
J Neuroendocrinol
. 2009 Feb;
2(6):803-6.
PMID: 19215422
Abstract Autoregulation of receptor systems by their own ligands is a well established biological phenomenon. While down-regulation of the glucocorticoid binding capacity by glucocorticoids has been shown in animals and...
8.
Hoffken G, Barth J, Rubinstein E, Beckmann H
Infection
. 2007 Nov;
35(6):414-20.
PMID: 18034211
Background: Empiric treatment of hospital-acquired pneumonia (HAP) should be focused on the suspected pathogens. We evaluated the efficacy and safety of moxifloxacin vs ceftriaxone in patients with HAP without risk...
9.
Frank T, Michelbrink M, Beckmann H, Schollhorn W
Biol Cybern
. 2007 Nov;
98(1):19-31.
PMID: 18026746
Differential learning is a learning concept that assists subjects to find individual optimal performance patterns for given complex motor skills. To this end, training is provided in terms of noisy...
10.
Kniemeyer H, Sporkmann C, Beckmann H, Martinez R, Sabin-Luzius U, Salem A, et al.
Chirurg
. 2007 Feb;
78(3):236-45.
PMID: 17318463
Background: Thromboendarterectomy (TEA) and stenting are in competition for treatment of carotid artery lesions. Both treatment modalities have to improve significantly. The goal of the study was to evaluate the...